Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
Links relacionados
- Similares en SciELO
Compartir
Anales de la Facultad de Medicina
versión impresa ISSN 1025-5583
Resumen
SOSA ROSADO, José Manuel. New oral anticoagulants in thromboembolism prevention in nonvalvular atrial fibrillation. An. Fac. med. [online]. 2013, vol.74, n.2, pp.139-144. ISSN 1025-5583.
Atrial fibrillation is the most frequent cardiac arrhythmia in clinical practice. The value of anticoagulation with vitamin K antagonists like warfarin in the prevention of embolic phenomena is widely demonstrated but managing is difficult because of its known interactions with other drugs and even food. Looking for the ideal anticoagulant in the last years new antithrombotic agents have appeared and others are in advanced phases of investigation. In the current review results of new anticoagulant agents development and expectations, opportunities and challenges are described in regards to direct thrombin and Xa factor inhibitors.
Palabras clave : Atrial fibrillation; warfarin; direct thrombin inhibitors; direct factor Xa inhibitors.